Organisation paid for research Program year 2024 Source: CMS Open Payments

EvergreenHealth

Neither a doctor nor a teaching hospital

Research payments

$539,552

88 payments

Through program year 2024, EvergreenHealth is reported as receiving $539,552 in research payments, across 88 payments.

By program year

6 rows

Year	Kind	Amount	Payments
2024	Research	$109,392	20
2023	Research	$105,594	17
2022	Research	$121,973	6
2021	Research	$24,389	12
2020	Research	$170,284	31
2019	Research	$7,920	2

Breakdown

Who paid Research payments · program years 2019–2024

Pfizer Inc. $168,851 22 payments
AbbVie, Inc. $168,687 30 payments
TG Therapeutics, Inc. $125,551 20 payments
Celgene Corporation $52,859 2 payments
Merck Sharp & Dohme Corporation $12,797 2 payments
Abbott Laboratories $7,920 2 payments
Boston Scientific Corporation $2,887 10 payments

Studies the money was for Research payments · program years 2019–2024

A Phase 3 Randomized Observerblinded Study to Evaluate the Efficacy Safety Tolerability and Immunogenicity of A Modified Rna Vaccine Against Influenza Compared to Licensed Inactivated Influenza Vaccine in Healthy Adults 18 Years of Age Or Older $168,851 22 payments
(ENHANCE) Evaluating the maintenance of efficacy when transitioning from current anti-CD20 therapy to ublituximab $114,626 18 payments
M14-397 $72,678 10 payments
M18-918 $54,873 10 payments
A Multicenter, Longitudinal, Open-Label, Single-Ar - A Multicenter, Longitudinal, Open-Label, Single-Arm Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated with Ozanimod (RPC-1063) $42,557 1 payment
M15-741 $21,386 8 payments
M19-304 $17,750 1 payment
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Tolerability, Efficacy, and Immunogenicity of V590 rVSV G-SARS-CoV-2-S, Live in Healthy Individuals 16 Years of Age or Older $11,200 1 payment
(ENABLE) REal world experieNce with BRIUMVI (ublituximAB-xiiy) treated patients: a Longitudinal rEgistry study $10,925 2 payments
A Multicenter, Longitudinal, Open-Label, Single-Ar $10,302 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.